Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency

Darin Salloum(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Neal Van Hoeven(Sana Biotechnology (United States)), Paul Brunetta(Pharmaceutical Product Development (United States)), Jasmin Kristianto(Sana Biotechnology (United States)), Kwang Bom Choi(Sana Biotechnology (United States)), Pascal Beauchesne(Sana Biotechnology (United States)), Christina Chaivorapol(Sana Biotechnology (United States)), Jaclyn Lock(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), John S. Yu(Cedars-Sinai Medical Center), Allison O’Rourke(Sana Biotechnology (United States)), Aaron Lampano(Fred Hutch Cancer Center), Athena W. Wong(Sana Biotechnology (United States)), Kavita Tundwal(Sana Biotechnology (United States)), Dave Shivak(Sana Biotechnology (United States)), Lisa Arjes(Sana Biotechnology (United States)), Ashley Ranere(Sana Biotechnology (United States)), Weidong Zhang(Hangzhou Hospital of Traditional Chinese Medicine), Jessica Li(Sana Biotechnology (United States)), Tiffany Wan(Sana Biotechnology (United States)), Adam Johnson(Sana Biotechnology (United States)), Hosein Kouros‐Mehr(University of California, San Francisco), John S. Lam(Sana Biotechnology (United States)), Ben Lam(Sana Biotechnology (United States))
Blood
November 2, 2023
Cited by 0


Related Papers